FIIs Took A Fresh Entry Into This Micro-Cap Company: Multibagger Penny Stock Below Rs 5 Hit Upper Circuit & 52-Week High On October 03
The stock gave multibagger returns of 167 per cent from its 52-week low of Rs 1.55 per share.
Today, shares of Evexia Lifecare Ltd hit a 5 per cent upper circuit and made a new 52-week high of Rs 4.14 per share from its previous closing of Rs 3.95 on BSE. The stock gave multibagger returns of 167 per cent from its 52-week low of Rs 1.55 per share. The company has not made any significant announcements. Hence, the rally in the share price could be driven purely by the market forces.
Earlier, the company issued up to 24,00,00,000 convertible warrants for Rs 3.60 per warrant. Each warrant can be converted into one fully paid-up equity share of the company with a face value of Re 1 and a premium of Rs 2.60, aggregating to a total of Rs 86,40,00,000. The proposed allottees will be required to pay 25 per cent of the total issue size upfront upon issuing the warrants. The warrants will be issued on a private placement basis and will be convertible into equity shares within 18 months from the date of issue. The issue price per warrant is Rs 3.60, and the total number of investors is two: Raghuvir International Pvt Ltd and Shree Saibaba Exim Pvt Ltd. 12,00,00,000 warrants to each investor have been allocated.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
Evexia Lifecare Limited formerly known as Kavit Industries Limited is engaged in the trading of chemicals, agricultural produce and various other products of consumer goods. The company has also formed a new subsidiary firm to set up pathology labs in Africa.
According to the financials, this FMCG company has a market cap of Rs 462.61 crore and reported positive numbers in its Quarterly Results (Q1FY25) and annual results (FY24). In Q1FY25, FIIs took a fresh entry & bought over 1 per cent stake or 1,07,00,000 shares in the company. Investors should keep an eye on this micro-cap stock under the radar.
Disclaimer: The article is for informational purposes only and not investment advice.